scispace - formally typeset
N

Naganari Ohkura

Researcher at Osaka University

Publications -  87
Citations -  8432

Naganari Ohkura is an academic researcher from Osaka University. The author has contributed to research in topics: FOXP3 & Gene. The author has an hindex of 35, co-authored 77 publications receiving 6825 citations. Previous affiliations of Naganari Ohkura include Kyoto University.

Papers
More filters
Journal ArticleDOI

A promoter-level mammalian expression atlas

Alistair R. R. Forrest, +280 more
- 27 Mar 2014 - 
TL;DR: For example, the authors mapped transcription start sites (TSSs) and their usage in human and mouse primary cells, cell lines and tissues to produce a comprehensive overview of mammalian gene expression across the human body.
Journal ArticleDOI

Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1

TL;DR: It is shown that the transcription factor AML1 (acute myeloid leukaemia 1)/Runx1 (Runt-related transcription factor 1), which is crucially required for normal haematopoiesis including thymic T-cell development, activates IL-2 and IFN-γ gene expression in conventional CD4+ T cells through binding to their respective promoters.
Journal ArticleDOI

Development and Maintenance of Regulatory T cells

TL;DR: Understanding how epigenetic alterations and Foxp3 expression coordinately control Treg-cell-specific gene regulation will enable better control of immune responses by targeting the generation and maintenance of Treg cells.
Journal ArticleDOI

T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Development

TL;DR: It is shown that Treg cell development was achieved by the combination of two independent processes, i.e., the expression of Foxp3 and the establishment of TReg cell-specific CpG hypomethylation pattern, and those T cells in which the two events have concurrently occurred are developmentally set into the T Reg cell lineage.
Journal ArticleDOI

Two FOXP3 + CD4 + T cell subpopulations distinctly control the prognosis of colorectal cancers

TL;DR: Depletion of FOXP3hi Treg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population ofFOXP3lo non-Treg cells could be used to suppress or prevent tumor formation.